Nordea Investment Management
IART icon

Nordea Investment Management’s Integra LifeSciences IART Stock Holding History

Nordea Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-129,166
Closed -$1.59M – 864
2025
Q2 		$1.59M Sell
129,166
-406
-0.3% -$5.9K ﹤0.01% 762
2025
Q1 		$2.87M Buy
129,572
+1,664
+1% +$39.1K ﹤0.01% 637
2024
Q4 		$2.92M Buy
127,908
+5,032
+4% +$110K ﹤0.01% 626
2024
Q3 		$2.19M Buy
122,876
+27,237
+28% +$631K ﹤0.01% 675
2024
Q2 		$2.78M Sell
95,639
-15,056
-14% -$447K ﹤0.01% 638
2024
Q1 		$3.84M Buy
110,695
+15,244
+16% +$610K ﹤0.01% 592
2023
Q4 		$4.18M Sell
95,451
-4,822
-5% -$190K 0.01% 569
2023
Q3 		$3.86M Sell
100,273
-2,104
-2% -$88.5K 0.01% 558
2023
Q2 		$4.22M Sell
102,377
-42,728
-29% -$2.06M 0.01% 550
2023
Q1 		$8.27M Sell
145,105
-3,520
-2% -$198K 0.01% 412
2022
Q4 		$8.32M Sell
148,625
-2,518
-2% -$128K 0.01% 408
2022
Q3 		$6.63M Sell
151,143
-1,359
-0.9% -$69.6K 0.01% 451
2022
Q2 		$8.3M Buy
152,502
+28,589
+23% +$1.72M 0.01% 411
2022
Q1 		$8.17M Buy
123,913
+4,119
+3% +$271K 0.01% 468
2021
Q4 		$8.17M Buy
119,794
+20,974
+21% +$1.42M 0.01% 461
2021
Q3 		$7M Sell
98,820
-533
-0.5% -$37.7K 0.01% 525
2021
Q2 		$6.78M Buy
99,353
+9,406
+10% +$665K 0.01% 537
2021
Q1 		$6.21M Sell
89,947
-5,914
-6% -$401K 0.01% 523
2020
Q4 		$6.22M Sell
95,861
-1,860
-2% -$100K 0.01% 468
2020
Q3 		$4.55M Sell
97,721
-95,711
-49% -$4.55M 0.01% 504
2020
Q2 		$8.94M Buy
193,432
+96,347
+99% +$4.74M 0.01% 493
2020
Q1 		$4.2M Buy
97,085
+4,133
+4% +$217K 0.01% 469
2019
Q4 		$5.42M Buy
92,952
+2,913
+3% +$173K 0.01% 463
2019
Q3 		$5.42M Buy
90,039
+201
+0.2% +$12K 0.01% 440
2019
Q2 		$5.02M Buy
89,838
+14,077
+19% +$725K 0.01% 472
2019
Q1 		$4.22M Sell
75,761
-1,005
-1% -$51.2K 0.01% 672
2018
Q4 		$3.46M Sell
76,766
-493
-0.6% -$27K 0.01% 694
2018
Q3 		$5.09M Buy
+77,259
New +$4.8M 0.01% 547

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management's IART Position: Q3 2025 in Review

Nordea Investment Management sold out of Integra LifeSciences (IART) in Q3 2025, closing a stake of 129,166 shares — an estimated $1.59M sold.

Nordea Investment Management first reported a position in IART in Q3 2018 and held it in 28 quarters. The position peaked at $8.94M in Q2 2020. 207 funds tracked by Wall St. Rank hold IART as of Q3 2025.

  • Nordea Investment Management reported no remaining Integra LifeSciences position as of Q3 2025 after selling out during the quarter.
  • Nordea Investment Management sold 129,166 Integra LifeSciences shares in Q3 2025, an estimated $1.59M.
  • Nordea Investment Management first reported a position in Integra LifeSciences in Q3 2018 and held it in 28 quarters.
  • Nordea Investment Management's Integra LifeSciences position peaked at $8.94M in Q2 2020.
  • 207 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2025.

Based on Nordea Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.